MATERIALS AND METHODS

Patients.
Twenty-two patients undergoing high-dose chemoradiotherapy followed by autobogous BMT were studied. Only patients with at least a follow-up of 60 days were included, while halfof them had a follow-up of more than 180 days. their disease two to six months after BMT, two (one TC and one NHL) had a relapse after seven and nine months. One patient with a T cell NHL developed an acute myeloid leukemia after six months, which did not respond to chemotherapy.
From the nine patients alive and well without a relapse, three (two AL and one IC) have had a follow-up of more than one year and three (two NHL and one AL) more than two years.
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